Presentation Controversies and Advances 2021 Treating Stenosis or Ischemia Does Not Improve Clinical Outcomes – Medical Therapy Is King (and Queen) Presenter: William E. Boden December 03, 2021
Presentation BIT 2020 Ischemia, Orbita, Courage trials will bring down Coronary Revascularization Significantly Presenter: Baren Chakraborty February 02, 2020
Presentation TCT 2015 For This Patient, I Suggest Medical Management and Risk-Factor Reduction Alone (What Have COURAGE and FAME Taught Us?) Presenter: John D. Puskas, Michael E. Farkouh October 14, 2015
Presentation TCT 2015 HOT TOPIC 3: How Should Trials Be Interpreted When Technology Has Moved Faster Than the Results? FOCUS on SYNTAX, COURAGE, and FREEDOM Clinicians Perspective Presenter: Bernard J. Gersh, William S. Weintraub, Ajay J. Kirtane October 12, 2015
Presentation TCT 2015 HOT TOPIC 3: How Should Trials Be Interpreted When Technology Has Moved Faster Than the Results? FOCUS on SYNTAX, COURAGE, and FREEDOM Guideline Perspective Presenter: Bernard J. Gersh, William S. Weintraub, Patrick T. O'Gara October 12, 2015
Presentation TCT 2015 From COURAGE and BARI 2D to ISCHEMIA: What Answers Can We Expect (and Not Expect) From ISCHEMIA? Presenter: Ori Ben-Yehuda, Ajay J. Kirtane, Sripal Bangalore October 11, 2015
Presentation COURAGE Substudy: OMT With or Without PCI in Women With Stable Coronary Disease Presenter: S. Acharjee July 31, 2015
Presentation Predicting Outcome in the COURAGE Trial: Coronary Anatomy vs. Ischemia Presenter: G.B. John Mancini January 14, 2014
Presentation Changes in Geographic Variation in Use of PCI for Stable Ischemic Heart Disease after COURAGE Presenter: Arun V. Mohan December 26, 2013
Presentation TCT 2013 On the PROSPECT of Reconciling COURAGE and FAME Presenter: Jagat Narula October 30, 2013
Presentation Frequency, Predictors, and Consequences of Crossing Over to Revascularization Within 12 Months of Randomization to Optimal Medical Therapy in COURAGE Presenter: John A. Spertus July 17, 2013
Presentation TCTAP 2013 The Fate of PCI for Multi-Vessel Disease From COURAGE to Syntax Presenter: Seung-Jung Park April 24, 2013
Presentation TCT 2012 Are COURAGE and FAME Irrelevant (or Less Relevant) with Current Generation DES? Presenter: Dean Kereiakes October 22, 2012
Presentation TCT 2012 The Impact of XIENCE V® Everolimus-Eluting Coronary Stents on Health Status in COURAGE-Like Patients. Presenter: David R. Rutledge, James B. Hermiller, Jin Wang, Mitchell W. Krucoff January 03, 2012